← The Wire
DMACNasdaq
DiaMedica Therapeutics Inc.
Pharmaceutical Preparations · Z4 · CIK 1401040
Clinical-stage biopharmaceutical company developing therapies for severe ischemic disease and acute pancreatitis
$304M
Market cap
$7.22
Last close
+10.2%
1D
+22.6%
5D
395K
Volume
Price · last 39 sessions+19.3%
May 4L $5.33 · H $7.22Jun 29
146
Total filings
May 21, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteMay 21, 202610-QFORM 10-QMay 6, 20268-KResults of OperationsMay 6, 2026DEFA14AFORM DEFA14AApr 1, 2026DEF 14AFORM DEF 14AApr 1, 20268-KResults of OperationsMar 31, 202610-KFORM 10-KMar 30, 20268-KCompany UpdateJan 5, 20268-KReg FD Disclosure · Company UpdateDec 18, 202510-QFORM 10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KMaterial AgreementAug 12, 202510-QFORM 10-QAug 12, 20258-KResults of OperationsAug 12, 20258-KExecutive Change · Reg FD DisclosureAug 6, 20258-KMaterial Agreement · Equity IssuanceJul 21, 20258-KReg FD DisclosureJul 17, 20258-KShareholder VoteMay 15, 202510-QFORM 10-QMay 13, 20258-KResults of OperationsMay 13, 2025DEFA14AFORM DEFA14AMar 28, 2025DEF 14AFORM DEF 14AMar 28, 202510-KFORM 10-KMar 17, 20258-KResults of OperationsMar 17, 20258-KExecutive ChangeMar 6, 20258-KExecutive Change · Reg FD DisclosureFeb 24, 202510-QFORM 10-QNov 13, 20248-KResults of Operations · Reg FD DisclosureNov 13, 20248-KResults of OperationsAug 7, 202410-QFORM 10-QAug 7, 2024SC 13GSC 13GJul 8, 20248-KMaterial Agreement · Equity IssuanceJun 26, 20248-KReg FD Disclosure · Company UpdateJun 26, 20248-KExecutive Change · Shareholder VoteMay 23, 202410-QFORM 10-QMay 8, 20248-KResults of OperationsMay 8, 20248-KExecutive ChangeApr 10, 2024DEFA14AFORM DEFA14AApr 4, 2024DEF 14AFORM DEF 14AApr 4, 202410-KFORM 10-KMar 19, 20248-KResults of OperationsMar 19, 202410-QFORM 10-QNov 13, 20238-KResults of Operations · Reg FD DisclosureNov 13, 20238-KExecutive ChangeSep 5, 202310-QFORM 10-QAug 14, 20238-KResults of OperationsAug 14, 20238-KMaterial Agreement · Equity IssuanceJun 21, 20238-KReg FD DisclosureJun 21, 20238-KCompany UpdateJun 21, 20238-KExecutive Change · Reg FD DisclosureMay 30, 20238-KReg FD Disclosure · Company UpdateMay 22, 20238-KBylaw Amendment · Shareholder VoteMay 18, 202310-QFORM 10-QMay 15, 20238-KResults of OperationsMay 15, 2023DEFA14AFORM DEFA14AApr 4, 2023DEF 14AFORM DEF 14AApr 4, 202310-KFORM 10-KMar 28, 20238-KResults of OperationsMar 28, 20238-KReg FD DisclosureMar 10, 20238-K/AExecutive ChangeMar 10, 20238-KExecutive Change · Reg FD DisclosureMar 6, 202310-QFORM 10-QNov 9, 20228-KResults of OperationsNov 9, 20228-KResults of Operations · Company UpdateOct 26, 202210-QFORM 10-QAug 11, 20228-KResults of OperationsAug 10, 20228-KCompany UpdateJul 6, 20228-KMaterial AgreementJun 29, 2022SC 13GSC 13GMay 27, 20228-KExecutive ChangeMay 25, 20228-KExecutive Change · Shareholder VoteMay 19, 202210-QFORM 10-QMay 4, 20228-KResults of OperationsMay 4, 2022DEFA14AFORM DEFA14AApr 5, 2022DEF 14AFORM DEF 14AApr 5, 202210-KFORM 10-KMar 14, 20228-KResults of OperationsMar 14, 20228-KCompany UpdateFeb 11, 202210-QFORM 10-QNov 10, 20218-KResults of OperationsNov 10, 2021
Insider Activity
In the 90 days to Nov 25, 2025: 1 insider bought $7.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 25, 2025 | Trill AbTenPercentOwner | Buy | 73,099 | $8.57 | $626K |
| Nov 24, 2025 | Trill AbTenPercentOwner | Buy | 40,253 | $7.89 | $318K |
| Nov 21, 2025 | Trill AbTenPercentOwner | Buy | 208,872 | $7.41 | $1.5M |
| Nov 20, 2025 | Trill AbTenPercentOwner | Buy | 128,426 | $7.41 | $952K |
| Nov 19, 2025 | Trill AbTenPercentOwner | Buy | 240,352 | $7.21 | $1.7M |
| Nov 18, 2025 | Trill AbTenPercentOwner | Buy | 182,882 | $6.75 | $1.2M |
| Nov 17, 2025 | Trill AbTenPercentOwner | Buy | 187,393 | $6.52 | $1.2M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance